Oramed Pharmaceuticals Inc.
ORMP· Nasdaq
ORMPOramed Pharmaceuticals Inc.
Filed Dec 12, 2012 · 10-K · 103 days after period end · 0001178913-12-003413
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|
| Net Income | -$1.33M | -$773.04K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oramed Pharmaceuticals Inc. · CIK 1176309 · Engraved from SEC EDGAR
ended Aug 31, 2012 · filed Dec 12, 2012 · 103 d after period end
